Literature DB >> 3295584

Iohexol 300 mg I/ml versus Iopamidol 300 mg I/ml for cervical myelography double blind trial.

J Valk, F C Crezée, R G de Slegte, G J Hazenberg, J Wolbers, T Bach-Gansmo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3295584     DOI： 10.1007/BF00327551

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


× No keyword cloud information.
  5 in total

1.  Iohexol. A non-ionic contrast medium. Pharmacology and toxicology.

Authors: 
Journal:  Acta Radiol Suppl       Date:  1980

2.  Lateral cervical, C1-C2, puncture in cervical myelography.

Authors:  J Valk
Journal:  Eur Neurol       Date:  1982       Impact factor: 1.710

3.  Neurotoxicity of iohexol: a new nonionic contrast medium.

Authors:  R N Bryan; R S Centeno; N Hershkowitz; R J Poelstra; M S Osato
Journal:  Radiology       Date:  1982-11       Impact factor: 11.105

4.  Iohexol versus metrizamide for cervical myelography: double-blind trial.

Authors:  S S Gebarski; T O Gabrielsen; J E Knake; J T Latack; P J Yang; J T Hoff
Journal:  AJNR Am J Neuroradiol       Date:  1985 Nov-Dec       Impact factor: 3.825

5.  Iohexol vs. metrizamide: study of efficacy and morbidity in cervical myelography.

Authors:  R E Latchaw; W L Hirsch; J A Horton; D Bissonette; D D Shaw
Journal:  AJNR Am J Neuroradiol       Date:  1985 Nov-Dec       Impact factor: 3.825
  5 in total
  1 in total

1.  Theory and practice: how much contrast for myelography?

Authors:  S F Halpin; P J Guest; J V Byrne
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.